Shares of McCormick & Company (NYSE: MKC) were down 1.8% on Thursday despite the company reporting better-than-expected earnings results for the third quarter of 2021. The stock has dropped 14% thus far this year and 14% over the past 12 months.
In Q3 2021, net sales increased 8% year-over-year to $1.55 billion. Sales from the Cholula and FONA acquisitions contributed 4% to the top line growth. Sales in the Consumer segment grew 1% while Flavor Solutions segment sales rose 21% versus the year-ago quarter. Higher sales drove a 5% growth in adjusted EPS to $0.80. Both the top and bottom line numbers surpassed market expectations.
During the quarter, the company continued to see demand for at-home food consumption as customers chose to stick to their pattern of cooking more meals at home, a trend which had gained traction during the pandemic. McCormick expects this trend to continue beyond the pandemic as people prefer more home-cooked and healthy options and believes this will help drive sales growth going forward.
The company faced tough comparisons as the year-ago period included the pandemic-driven surge in demand. Its total US branded portfolio consumption declined 10% in Q3 compared to a 31% consumption increase in the same period in 2020.
Consumption growth was 19% compared to Q3 2019 and this was led by double-digit growth in spices and seasonings, hot sauces and barbecue sauce. Household penetration and repeat rates have grown versus 2019 and the company is seeing customers purchase more of its products than they were pre-pandemic.
McCormick is also seeing a recovery in the foodservice industry which helped drive sales in the Flavour Solutions segment. The company expects this recovery to continue over the coming months and believes this will help drive growth.
Like its peers, McCormick is facing cost pressures. In Q3, higher inflation and industry-wide logistics challenges took a toll on profit. The company plans on tackling inflation through pricing and other strategies.
McCormick raised its sales guidance for fiscal year 2021 but pared its outlook for adjusted EPS. The company now expects sales to grow 12-13% versus FY2020. The earlier projection was for a growth of 11-13%. Adjusted EPS is now expected to range between $2.97-3.02 versus the previous outlook of $3.00-3.05. The decrease was driven by revisions to adjusted operating income that reflect higher inflation and logistics challenges.
Click here to read the full transcript of McCormick’s Q3 2021 earnings conference call
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
MKC Earnings: Key quarterly highlights from McCormick & Company’s Q1 2023 financial results
McCormick & Company, Incorporated (NYSE: MKC) reported first quarter 2023 earnings results today. Sales increased 3% year-over-year to $1.56 billion. Sales growth was 5% in constant currency. Net income was $139.1
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company's full-year net loss narrowed from the prior year.
Can KB Home (KBH) beat market headwinds in 2023?
KB Home (NYSE: KBH) has been expanding its presence beyond the key markets lately, while also diversifying homebuilding operations by offering highly customized options to customers. The downturn in the